CTRI/2018/03/012764
Recruiting
未知
The Value of Nephrocheck (NC)as an early predictor of Acute Kidney injury post-Cardiac Surgery.
Ortho Clinical Diagnostic0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients undergoing cardiac surgery
- Sponsor
- Ortho Clinical Diagnostic
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Patients who underwent cardiac surgery at NH hospital.
- •2 Use of indwelling urinary catheter as standard care expected for at least 48 hours after enrolment.
- •3 Expected to remain in the ICU for at least 48 hours after enrolment
Exclusion Criteria
- •1 Known AKI prior to surgery (KDIGO\-2012\).
- •2 Pregnant women.
- •3 Previous renal transplantation.
- •4 Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrolment.
- •\- Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic).
- •\- Subjects with a history of Chronic Kidney Disease (CKD) without a baseline serum creatinine value within 6 months of enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Benefit of early detection and nephrologic intervention of acute kidney injury in hospital (BE NECIA)Diseases of the circulatory systemKCT0002010Seoul National University Bundang Hospital20,000
Completed
Not Applicable
Effectiveness of NephroCheckTM Test to Predict Acute Kidney Injury Following Advanced Cardiac Replacement TherapiesAcute Kidney InjuryHeart FailureNCT02827448Baylor Research Institute300
Recruiting
Not Applicable
Risk Prediction for Contrast Induced Nephropathy in patients with renal impairmentHealth Condition 1: - Health Condition 2: I219- Acute myocardial infarction, unspecifiedCTRI/2019/06/019604GE Healthcare Limited
Recruiting
Not Applicable
Risk prediction of Contrast-Induced Nephropathykidneydamage because of contrast10029149NL-OMON35012niversitair Medisch Centrum Sint Radboud4,500
Completed
Not Applicable
Prognostic evaluation with focus on renal function of molecular target drugs for Unresectable or Metastatic Renal Cell Carcinoma patients with Renal DysfunctioJPRN-UMIN000021981Shinshu University school of medicine30